Evidence map›Paper›PMID 22467489›Full record

ArticleProtein science : a publication of the Protein Society2012

On the unyielding hydrophobic core of villin headpiece.

Jeffrey W Brown, Jeremiah D Farelli, C James McKnight

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jeffrey W BrownDepartment of Physiology and Biophysics, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Jeremiah D Farelli
C James McKnight

Funding

Localizing and Modeling Headpiece Domains on F-ActinR01GM062886 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MCKNIGHT, CHRISTOPHER JAMES · 2002 to 2006
$1.2M
NIGMS NIH HHS GM62886
6 · The paper itself

Abstract

Villin headpiece (HP67) is a small, autonomously-folding domain that has become a model system for understanding the fundamental tenets governing protein folding. In this communication, we explore the role that Leu61 plays in the structure and stability of the construct. Deletion of Leu61 results in a completely unfolded protein that cannot be expressed in Escherichia coli. Omission of only the aliphatic leucine side chain (HP67 L61G) perturbed neither the backbone conformation nor the orientation of local hydrophobic side chains. As a result, a large, solvent-exposed hydrophobic pocket, a negative replica of the leucine side-chain, was created on the surface. The loss of the hydrophobic interface between leucine 61 and the hydrophobic pocket destabilized the construct by ~3.3 kcal/mol. Insertion of a single glycine residue immediately before Leu61 (HP67 L61[GL]) was also highly destabilizing and had the effect of altering the backbone conformation (α-helix to π-helix) in order to precisely preserve the wild-type position and conformation of all hydrophobic residues, including Leu61. In addition to demonstrating that the hydrophobic side-chain of Leu61 is critically important for the stability of villin headpiece, our results are consistent with the notion that the precise interactions present within the hydrophobic core, rather than the hydrogen bonds that define the secondary structure, specify a protein's fold.

Indexed as

Amino Acid SequenceCrystallography, X-RayHydrogen BondingHydrophobic and Hydrophilic InteractionsLeucineMicrofilament ProteinsModels, MolecularMolecular Sequence DataPoint MutationProtein ConformationProtein FoldingProtein StabilitySequence AlignmentStatic ElectricityThermodynamicsLeucineMicrofilament Proteinsvillin

Identifiers

PMID22467489
PMCPMC3403462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.